Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study.
Daniel MrakElisabeth SimaderDaniela SieghartPeter MandlHelga RadnerThomas PerkmannHelmuth HaslacherMargareta MayerMaximilian KoblischkePhilipp HoferLisa GöschlFelix KartnigThomas DeimelAndreas KerschbaumerThomas HummelBarbara KornekRenate ThalhammerKarin StiasnyStefan WinklerJosef S SmolenJudith H AberleDaniel AletahaLeonhard X HeinzMichael Markus BonelliPublished in: Annals of the rheumatic diseases (2022)
2021-002348-57.